CN103099793B - 片剂及其制备方法 - Google Patents
片剂及其制备方法 Download PDFInfo
- Publication number
- CN103099793B CN103099793B CN201310049836.6A CN201310049836A CN103099793B CN 103099793 B CN103099793 B CN 103099793B CN 201310049836 A CN201310049836 A CN 201310049836A CN 103099793 B CN103099793 B CN 103099793B
- Authority
- CN
- China
- Prior art keywords
- tablet
- filler
- preparation
- mixed
- fluidizer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000000203 mixture Substances 0.000 claims abstract description 44
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 32
- 239000000945 filler Substances 0.000 claims abstract description 26
- 239000000314 lubricant Substances 0.000 claims abstract description 19
- 239000000853 adhesive Substances 0.000 claims abstract description 14
- 230000001070 adhesive effect Effects 0.000 claims abstract description 14
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 18
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims description 17
- 235000019136 lipoic acid Nutrition 0.000 claims description 17
- 229960002663 thioctic acid Drugs 0.000 claims description 17
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 14
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 8
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 8
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 8
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 8
- 235000019359 magnesium stearate Nutrition 0.000 claims description 7
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 6
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000002372 labelling Methods 0.000 claims description 4
- 239000003550 marker Substances 0.000 claims description 4
- 239000000741 silica gel Substances 0.000 claims description 4
- 229910002027 silica gel Inorganic materials 0.000 claims description 4
- 239000003814 drug Substances 0.000 abstract description 14
- 238000000034 method Methods 0.000 abstract description 13
- 229940079593 drug Drugs 0.000 abstract description 6
- 238000004090 dissolution Methods 0.000 abstract description 5
- 238000007873 sieving Methods 0.000 abstract 1
- 238000007906 compression Methods 0.000 description 11
- 230000006835 compression Effects 0.000 description 7
- 239000000843 powder Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000007907 direct compression Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 2
- 238000005461 lubrication Methods 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310049836.6A CN103099793B (zh) | 2013-02-06 | 2013-02-06 | 片剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310049836.6A CN103099793B (zh) | 2013-02-06 | 2013-02-06 | 片剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103099793A CN103099793A (zh) | 2013-05-15 |
CN103099793B true CN103099793B (zh) | 2015-07-15 |
Family
ID=48308205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310049836.6A Expired - Fee Related CN103099793B (zh) | 2013-02-06 | 2013-02-06 | 片剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103099793B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103655495B (zh) * | 2013-11-08 | 2015-06-10 | 南京瑞尔医药有限公司 | 一种辅料种类和用量少的硫辛酸片剂及其制备方法 |
CN103622927A (zh) * | 2013-12-09 | 2014-03-12 | 山东齐都药业有限公司 | 硫辛酸片及其制备方法 |
CN105267164B (zh) * | 2014-07-04 | 2019-11-05 | 江苏神龙药业股份有限公司 | 硫辛酸分散片及其制备方法 |
CN104622827A (zh) * | 2015-03-05 | 2015-05-20 | 重庆华邦制药有限公司 | 托法替布片剂及其制备方法 |
CN105147614B (zh) * | 2015-08-13 | 2018-07-20 | 河北神威药业有限公司 | 一种包含bibw 2992ma2的固体制剂及其制备方法 |
CN105147615B (zh) * | 2015-08-17 | 2018-10-19 | 上海市肿瘤研究所 | 肿瘤细胞及肿瘤血管双靶向纳米粒、构建方法及应用 |
CN111557920A (zh) * | 2020-04-15 | 2020-08-21 | 南京海纳医药科技股份有限公司 | 一种含有硫辛酸的片剂及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1449757A (zh) * | 2003-04-30 | 2003-10-22 | 江西省药物研究所 | 一种多潘立酮口崩片制剂及其制法 |
CN1997354A (zh) * | 2004-03-17 | 2007-07-11 | 诺瓦提斯公司 | 有机化合物的盖仑制剂 |
EP1928431B1 (en) * | 2005-08-26 | 2008-12-31 | Egis Gyógyszergyár Nyilvánosan Múködö Részvénytársaság | Controlled release pharmaceutical composition containing carvedilol |
CN101564457A (zh) * | 2008-04-23 | 2009-10-28 | 北京星昊医药股份有限公司 | 三白草木脂素分散片 |
CN101601661A (zh) * | 2009-07-08 | 2009-12-16 | 昆明积大制药有限公司 | 一种利塞膦酸钠片剂及其制备方法 |
CN102078321A (zh) * | 2010-12-31 | 2011-06-01 | 泰州万全医药科技有限公司 | 一种含布南色林的药物组合物及其制备方法 |
CN102614140A (zh) * | 2011-01-26 | 2012-08-01 | 浙江九洲药物科技有限公司 | 伊潘立酮口崩片及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1739501A (zh) * | 2005-09-22 | 2006-03-01 | 上海交通大学 | 用于治疗控制糖尿病性神经病变的硫辛酸包衣片剂 |
CN102796073A (zh) * | 2011-11-10 | 2012-11-28 | Cbb网络股份有限公司 | 制备(R)α-硫辛酸盐的方法、其制剂以及在含有该盐的片剂形式的药物组合物中的用途 |
-
2013
- 2013-02-06 CN CN201310049836.6A patent/CN103099793B/zh not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1449757A (zh) * | 2003-04-30 | 2003-10-22 | 江西省药物研究所 | 一种多潘立酮口崩片制剂及其制法 |
CN1997354A (zh) * | 2004-03-17 | 2007-07-11 | 诺瓦提斯公司 | 有机化合物的盖仑制剂 |
EP1928431B1 (en) * | 2005-08-26 | 2008-12-31 | Egis Gyógyszergyár Nyilvánosan Múködö Részvénytársaság | Controlled release pharmaceutical composition containing carvedilol |
CN101564457A (zh) * | 2008-04-23 | 2009-10-28 | 北京星昊医药股份有限公司 | 三白草木脂素分散片 |
CN101601661A (zh) * | 2009-07-08 | 2009-12-16 | 昆明积大制药有限公司 | 一种利塞膦酸钠片剂及其制备方法 |
CN102078321A (zh) * | 2010-12-31 | 2011-06-01 | 泰州万全医药科技有限公司 | 一种含布南色林的药物组合物及其制备方法 |
CN102614140A (zh) * | 2011-01-26 | 2012-08-01 | 浙江九洲药物科技有限公司 | 伊潘立酮口崩片及其制备方法 |
Non-Patent Citations (1)
Title |
---|
黄朝霞等,.粉末直接压片法制备制霉素片.《中南药学》.2008,第6卷(第2期),第184-185页. * |
Also Published As
Publication number | Publication date |
---|---|
CN103099793A (zh) | 2013-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103099793B (zh) | 片剂及其制备方法 | |
CN101889987B (zh) | 一种头孢克肟片及胶囊的制备方法 | |
CN103301084B (zh) | 一种盐酸小檗碱片及其制备方法 | |
JP2002531491A (ja) | ヒドロコロイドおよびセルロースエーテルを含む持続放出性錠剤 | |
WO2008015162A1 (en) | Gastro retentive delivery system | |
CN102885795A (zh) | 盐酸曲美他嗪缓释片及其制备方法 | |
CN101390846B (zh) | 一种阿莫西林胶囊剂及其生产方法 | |
CN104523791B (zh) | 一种鲜人参活性提取物口崩片及其制备方法 | |
CN104586798A (zh) | 一种吉非替尼分散片及其制备方法 | |
CN106137988A (zh) | 一种甲硝唑固体制剂及其制备方法 | |
CN103610658A (zh) | 一种免疫调节剂缓释剂及其制备方法 | |
CN103393612B (zh) | 马来酸依那普利口腔崩解片的制备方法 | |
CN103006603B (zh) | 醋酸乌利司他的固体分散体及固体制剂 | |
CN102451171B (zh) | 替硝唑阴道泡腾片及其制备方法 | |
CN105310990A (zh) | 一种防止粘冲和裂片的对乙酰氨酚片及其制备方法 | |
CN102018801B (zh) | 一种新健胃片及其制备方法 | |
CN104435447B (zh) | 一种葛山降脂缓释制剂及其制备方法 | |
CN103393614B (zh) | 一种盐酸哌罗匹隆缓释制剂及制备方法 | |
CN103251566A (zh) | 片剂及其制备方法 | |
CN101732725B (zh) | 一种加速片剂崩解的组合物及其应用 | |
CN104013684A (zh) | 一种盆炎净片剂及其制备方法 | |
CN104367563A (zh) | 一种含有灰树花的片剂及其制备方法 | |
CN110101673A (zh) | 一种盐酸曲马多分散片的制备方法 | |
CN104337783B (zh) | 一种卡培他滨片剂及其制备方法 | |
CN117017932B (zh) | 一种舒林酸片组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Gao Shen Inventor after: Zhang Lijuan Inventor after: Dai Ziyuan Inventor after: Wei Zhongming Inventor after: Zhu Quangang Inventor after: Ding Xueying Inventor after: Gao Jing Inventor after: Liu Jiyong Inventor after: Wang Xiaoyu Inventor after: Zhang Min Inventor before: Gao Shen Inventor before: Dai Ziyuan Inventor before: Zhu Quangang Inventor before: Ding Xueying Inventor before: Gao Jing Inventor before: Liu Jiyong Inventor before: Wang Xiaoyu Inventor before: Zhang Min Inventor before: Zhang Lijuan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: GAO SHEN DAI ZIYUAN ZHU QUANGANG DING XUEYING GAO JING LIU JIYONG WANG XIAOYU ZHANG MIN ZHANG LIJUAN TO: GAO SHEN DAI ZIYUAN WEI ZHONGMING ZHU QUANGANG DING XUEYING GAO JING LIU JIYONG WANG XIAOYU ZHANG MIN ZHANG LIJUAN |
|
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Gao Shen Inventor after: Zhang Lijuan Inventor after: Mo Donghai Inventor after: Wang Xuebin Inventor after: Pang Yajuan Inventor after: Dai Ziyuan Inventor after: Wei Zhongming Inventor after: Zhu Quangang Inventor after: Ding Xueying Inventor after: Gao Jing Inventor after: Liu Jiyong Inventor after: Wang Xiaoyu Inventor after: Zhang Min Inventor before: Gao Shen Inventor before: Zhang Lijuan Inventor before: Dai Ziyuan Inventor before: Wei Zhongming Inventor before: Zhu Quangang Inventor before: Ding Xueying Inventor before: Gao Jing Inventor before: Liu Jiyong Inventor before: Wang Xiaoyu Inventor before: Zhang Min |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: GAO SHEN DAI ZIYUAN WEI ZHONGMING ZHU QUANGANG DING XUEYING GAO JING LIU JIYONG WANG XIAOYU ZHANG MIN ZHANG LIJUAN TO: GAO SHEN DAI ZIYUAN WEI ZHONGMING ZHU QUANGANG DING XUEYING GAO JING LIU JIYONG WANG XIAOYU ZHANG MIN ZHANG LIJUAN MO DONGHAI WANG XUEBIN PANG YAJUAN |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150715 Termination date: 20170206 |
|
CF01 | Termination of patent right due to non-payment of annual fee |